These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 12457448

  • 1. High prevalence of RET proto-oncogene activation (RET/PTC) in papillary thyroid carcinomas.
    Lam KY, Lo CY, Leung PS.
    Eur J Endocrinol; 2002 Dec; 147(6):741-5. PubMed ID: 12457448
    [Abstract] [Full Text] [Related]

  • 2. High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas.
    Lee CH, Hsu LS, Chi CW, Chen GD, Yang AH, Chen JY.
    J Clin Endocrinol Metab; 1998 May; 83(5):1629-32. PubMed ID: 9589668
    [Abstract] [Full Text] [Related]

  • 3. Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese.
    Liu RT, Chou FF, Wang CH, Lin CL, Chao FP, Chung JC, Huang CC, Wang PW, Cheng JT.
    Thyroid; 2005 Apr; 15(4):326-35. PubMed ID: 15876154
    [Abstract] [Full Text] [Related]

  • 4. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children.
    Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA.
    Cancer Res; 1997 May 01; 57(9):1690-4. PubMed ID: 9135009
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant.
    Thomas GA, Bunnell H, Cook HA, Williams ED, Nerovnya A, Cherstvoy ED, Tronko ND, Bogdanova TI, Chiappetta G, Viglietto G, Pentimalli F, Salvatore G, Fusco A, Santoro M, Vecchio G.
    J Clin Endocrinol Metab; 1999 Nov 01; 84(11):4232-8. PubMed ID: 10566678
    [Abstract] [Full Text] [Related]

  • 7. Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus.
    Smida J, Salassidis K, Hieber L, Zitzelsberger H, Kellerer AM, Demidchik EP, Negele T, Spelsberg F, Lengfelder E, Werner M, Bauchinger M.
    Int J Cancer; 1999 Jan 05; 80(1):32-8. PubMed ID: 9935226
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation.
    Bounacer A, Wicker R, Caillou B, Cailleux AF, Sarasin A, Schlumberger M, Suárez HG.
    Oncogene; 1997 Sep 05; 15(11):1263-73. PubMed ID: 9315093
    [Abstract] [Full Text] [Related]

  • 10. RET/PTC rearrangement in thyroid tumors.
    Nikiforov YE.
    Endocr Pathol; 2002 Sep 05; 13(1):3-16. PubMed ID: 12114746
    [Abstract] [Full Text] [Related]

  • 11. [Rearrangement of the RET gene in papillary thyroid carcinoma].
    Wiench M, Włoch J, Oczko M, Gubała E, Jarzab B.
    Wiad Lek; 2001 Sep 05; 54 Suppl 1():64-71. PubMed ID: 12182064
    [Abstract] [Full Text] [Related]

  • 12. RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH.
    Cinti R, Yin L, Ilc K, Berger N, Basolo F, Cuccato S, Giannini R, Torre G, Miccoli P, Amati P, Romeo G, Corvi R.
    Cytogenet Cell Genet; 2000 Sep 05; 88(1-2):56-61. PubMed ID: 10773666
    [Abstract] [Full Text] [Related]

  • 13. Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomas.
    Puxeddu E, Moretti S, Giannico A, Martinelli M, Marino C, Avenia N, Cristofani R, Farabi R, Reboldi G, Ribacchi R, Pontecorvi A, Santeusanio F.
    Eur J Endocrinol; 2003 May 05; 148(5):505-13. PubMed ID: 12720532
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident.
    Klugbauer S, Lengfelder E, Demidchik EP, Rabes HM.
    Oncogene; 1995 Dec 21; 11(12):2459-67. PubMed ID: 8545102
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia.
    Zou M, Shi Y, Farid NR.
    Cancer; 1994 Jan 01; 73(1):176-80. PubMed ID: 8275421
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia.
    Chua EL, Wu WM, Tran KT, McCarthy SW, Lauer CS, Dubourdieu D, Packham N, O'Brien CJ, Turtle JR, Dong Q.
    J Clin Endocrinol Metab; 2000 Aug 01; 85(8):2733-9. PubMed ID: 10946873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.